Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Hemophilia A With Inhibitor · Hemophilia A · CPRX

CATALYST PHARMACEUTICALS

CATALYST PHARMACEUTICALS, INC.

CATALYST PHARMACEUTICALS patent portfolio — 61 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US HQ
2002 Founded
179 Employees
Public company Type
CPRX · NYSE Ticker
Company details
Status
Public
HQ
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US
Founded
2002
Employees
179
Programs
23
Drugs
20
Patents
61
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

CATALYST PHARMACEUTICALS patents

61 pharmaceutical patents indexed for CATALYST PHARMACEUTICALS. 3 expire within 24 months.

CATALYST PHARMACEUTICALS has 61 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

61 patents

Patent portfolio

Page 1 of 2

  1. US 11806421

    Porous-cellulose particles and production method thereof, and cosmetic

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11701307

    Organic-inorganic composite particles, manufacturing method therefor, and cosmetic

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11491212

    Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11401513

    Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11384062

    Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11266724

    Modified factor VII polypeptides for subcutaneous administration and on-demand treatment

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11203749

    Factor VII polypeptides that are modified and uses thereof

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11020326

    Hollow particles and cosmetic

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10982203

    Modified factor IX polypeptides and uses thereof

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10954501

    Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10781435

    Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10716770

    Nicotinic receptor non-competitive antagonists

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10314769

    Organic-inorganic composite particles and cosmetic product

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10258582

    Nicotinic receptor non-competitive antagonists

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10167292

    Benzodiazepines as bromodomain inhibitors

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10160961

    Factor VII polypeptides that are modified and uses thereof

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10143636

    Porous silica particle and cleansing cosmetic

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9889072

    Porous silica particle, method for producing the same, and cleansing cosmetic containing the same

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9856467

    Modified factor X polypeptides and uses thereof

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9855195

    Dental curable composition

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9808407

    Porous silica particle, method for producing the same, and cosmetic containing the same

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9795655

    Modified MT-SP1 proteases that inhibit complement activation

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9476037

    Factor VII polypeptides that are modified and uses thereof

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9359598

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9327258

    Porous silica-based particles having smooth surface, method for production thereof and cosmetic comprising such particles

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9328339

    Modified factor IX polypeptides and uses thereof

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9290757

    Protease screening methods and proteases identified thereby

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9254274

    Method of treating Tourette'S disorder with GABA-aminotransferase inactivators

    Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9226881

    Multi-functional composite powder

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9145552

    Modified factor X polypeptides and uses thereof

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9011888

    Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9005638

    Cosmetics containing a multi-functional composite powder

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8969413

    Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8778870

    Modified factor IX polypeptides and uses thereof

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8663633

    Protease screening methods and proteases identified thereby

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8519103

    Factor VII polypeptides that are modified and uses thereof

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8486433

    Antibacterial deodorant

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8455564

    Dental composition and composite resin

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8445245

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8440739

    Dental composition and composite resin

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8436078

    Dental composition and composite resin

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8383388

    Modified coagulation factor IX polypeptides and use thereof for treatment

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8338107

    Method for producing polymers having a preselected activity

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8211428

    Protease screening methods and proteases identified thereby

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8182860

    Dental filler

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8048906

    Optically pure and enriched isomers of chelating ligands and contrast agents

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7981513

    Dental filler

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7939304

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does CATALYST PHARMACEUTICALS have?

61 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CATALYST PHARMACEUTICALS patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.